pre-IPO PHARMA
COMPANIES VC JOBS NEWS CONTACT

COMPANY OVERVIEW

Yumanity Therapeutics is transforming drug discovery for neurodegenerative diseases caused by protein misfolding. Yumanity Therapeutics is working to identify and develop new, disease-modifying therapies that address several illnesses with critical unmet medical needs.

LOCATION

  • Cambridge, MA, USA

    • THERAPEUTIC AREAS

  • Neurodegenerative Disease

    • WEBSITE

    https://www.yumanity.com/

    CAREER WEBSITE

    https://www.yumanity.com/careers/

    SOCIAL MEDIA

    INVESTORS

    alexandria-venture-investments biogen dolby-family-ventures fidelity-management-research-company redmile-group sanofi-ventures

    PRESS RELEASES


    Nov 18, 2019

    Yumanity Therapeutics Appoints Neuroscience Veteran, Brigitte Robertson, M.D., as Chief Medical Officer


    Oct 7, 2019

    Yumanity Therapeutics Initiates Phase 1 Clinical Trial of Lead Candidate YTX-7739 for the Treatment of Parkinson’s Disease


    Sep 5, 2019

    Yumanity Therapeutics Appoints Patricia Allen to its Board of Directors


    Jul 10, 2019

    Yumanity Therapeutics Appoints Richard Peters, M.D., Ph.D., as Chief Executive Officer


    May 23, 2019

    Yumanity Therapeutics to Present at the Jefferies 2019 Global Healthcare Conference


    For More Press Releases
    Google Analytics Alternative